Meritain Health policy
0995-Amivantamab-vmjw (Rybrevant) and Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro)
0995-Amivantamab-vmjw (Rybrevant) and Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) is a public Meritain Health policy (policy 0995). It lists 15 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
- Payer
- Meritain Health
- Policy number
- 0995
- Line of business
- Commercial
- Source
- www.aetna.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes.
| Code | Other Meritain Health policies |
|---|---|
| 81235 | Policies naming 81235 |
| 96413 | Policies naming 96413 |
| 96417 | Policies naming 96417 |
| J9045 | Policies naming J9045 |
| J9060 | Policies naming J9060 |
| J9061 | Policies naming J9061 |
| J9263 | Policies naming J9263 |
| J9294 | Policies naming J9294 |
| J9296 | Policies naming J9296 |
| J9297 | Policies naming J9297 |
| J9305 | Policies naming J9305 |
| J9314 | Policies naming J9314 |
| J9322 | Policies naming J9322 |
| J9323 | Policies naming J9323 |
| J9324 | Policies naming J9324 |